Image_1_Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation.TIF
Interleukin-19 (IL-19) acts as a negative-feedback regulator to limit proinflammatory response of macrophages and microglia in autocrine/paracrine manners in various inflammatory diseases. Multiple sclerosis (MS) is a major neuroinflammatory disease in the central nervous system (CNS), but it remains uncertain how IL-19 contributes to MS pathogenesis. Here, we demonstrate that IL-19 deficiency aggravates experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, by promoting IL-17-producing helper T cell (Th17 cell) infiltration into the CNS. In addition, IL-19-deficient splenic macrophages expressed elevated levels of major histocompatibility complex (MHC) class II, co-stimulatory molecules, and Th17 cell differentiation-associated cytokines such as IL-1β, IL-6, IL-23, TGF-β1, and TNF-α. These observations indicated that IL-19 plays a critical role in suppression of MS pathogenesis by inhibiting macrophage antigen presentation, Th17 cell expansion, and subsequent inflammatory responses. Furthermore, treatment with IL-19 significantly abrogated EAE. Our data suggest that IL-19 could provide significant therapeutic benefits in patients with MS.
History
References
- https://doi.org//10.1038/nrn784
- https://doi.org//10.1038/s41572-018-0041-4
- https://doi.org//10.1007/s00401-015-1402-7
- https://doi.org//10.1111/bph.12499
- https://doi.org//10.1038/nature04753
- https://doi.org//10.1038/sj.gene.6363714
- https://doi.org//10.1016/j.intimp.2004.01.005
- https://doi.org//10.1016/j.intimp.2004.01.007
- https://doi.org//10.4049/jimmunol.167.7.3545
- https://doi.org//10.1189/jlb.0807525
- https://doi.org//10.1002/ibd.21151
- https://doi.org//10.1371/journal.pone.0118640
- https://doi.org//10.1002/glia.22644
- https://doi.org//10.1038/ni.2637
- https://doi.org//10.1016/j.ajpath.2014.04.001
- https://doi.org//10.4049/jimmunol.182.2.802
- https://doi.org//10.1002/eji.200425523
- https://doi.org//10.4049/jimmunol.173.11.6712
- https://doi.org//10.1016/j.jaci.2008.04.016
- https://doi.org//10.1111/j.1600-0625.2006.00516.x
- https://doi.org//10.1038/nm804
- https://doi.org//10.1084/jem.20060244
- https://doi.org//10.1111/cei.12285
- https://doi.org//10.1093/rheumatology/ken061
- https://doi.org//10.1038/ng.381
- https://doi.org//10.1073/pnas.0709592105
- https://doi.org//10.4049/jimmunol.1501457
- https://doi.org//10.4049/jimmunol.1003307
- https://doi.org//10.1016/j.yjmcc.2014.11.002
- https://doi.org//10.1111/bph.14193
- https://doi.org//10.1016/j.immuni.2009.02.007
- https://doi.org//10.1002/eji.200425317
- https://doi.org//10.3109/00207459108985460
- https://doi.org//10.1146/annurev-immunol-051116-052350
- https://doi.org//10.1002/JLB.MR1117-471R
- https://doi.org//10.3389/fimmu.2019.00968
- https://doi.org//10.4049/jimmunol.169.8.4288
- https://doi.org//10.1159/000464135
- https://doi.org//10.1189/jlb.3A0116-028RR
- https://doi.org//10.1016/j.immuni.2013.11.022
- https://doi.org//10.1038/nature09447
- https://doi.org//10.1016/j.cell.2006.07.035
- https://doi.org//10.1038/nature04754
- https://doi.org//10.15252/embj.201694615
- https://doi.org//10.1146/annurev-immunol-032712-095910
- https://doi.org//10.1038/nri.2016.123
- https://doi.org//10.1007/s11910-005-0052-x
- https://doi.org//10.2147/NDT.S140634
- https://doi.org//10.1038/nri3766
- https://doi.org//10.1186/s40591-016-0046-x
- https://doi.org//10.1016/j.cytogfr.2010.08.004
- https://doi.org//10.1371/journal.pone.0040343
- https://doi.org//10.1073/pnas.1117218109
- https://doi.org//10.1073/pnas.1913997117
- https://doi.org//10.1038/nm1425
- https://doi.org//10.1073/pnas.0602574103
- https://doi.org//10.1615/CritRevImmunol.2016015517
- https://doi.org//10.1038/nrd.2017.267
- https://doi.org//10.1101/2020.07.15.204826
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity